Tissue Regeneration Technologies, LLC - Product Pipeline Analysis, 2015 Update

Date: August 25, 2015
Pages: 18
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T8D31D6DD64EN
Leaflet:

Download PDF Leaflet

Tissue Regeneration Technologies, LLC - Product Pipeline Analysis, 2015 Update
Summary

Tissue Regeneration Technologies, LLC (TRT) is a medical technology company that develops, manufactures and sells devices for urology, orthopedics and wound care markets. The company offers products such as lithogold, dermagold, cardiogold, orthogold, handpiece in hand frontal, vetgold and focal zone products and wound care products. Its softwave technology is used for the treatment of wounds, bones and ischemic heart tissue. TRT offers clinical research service and field services. The company has presence in the US and Switzerland. TRT is headquartered in Woodstock, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tissue Regeneration Technologies, LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Tissue Regeneration Technologies, LLC Company Snapshot
Tissue Regeneration Technologies, LLC Company Overview
Key Information
Tissue Regeneration Technologies, LLC Pipeline Products and Clinical Trials Overview
Tissue Regeneration Technologies, LLC – Pipeline Analysis Overview
Key Facts
Tissue Regeneration Technologies, LLC - Major Products and Services
Tissue Regeneration Technologies, LLC Pipeline Products by Development Stage
Tissue Regeneration Technologies, LLC Pipeline Products Overview
Cardiogold
Cardiogold Product Overview
DermaGold
DermaGold Product Overview
OrthoGold 280
OrthoGold 280 Product Overview
Tissue Regeneration Technologies, LLC - Key Competitors
Tissue Regeneration Technologies, LLC - Key Employees
Tissue Regeneration Technologies, LLC - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tissue Regeneration Technologies, LLC, Recent Developments
Jul 27, 2011: Tissue Regeneration Releases CPT Codes For ESWT In Wound Healing
Aug 31, 2009: Tissue Regeneration Technologies To Complete The Clinical Trial For Cardiogold In First Quarter Of 2010
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Tissue Regeneration Technologies, LLC, Key Facts
Tissue Regeneration Technologies, LLC Pipeline Products and Clinical Trials Overview
Tissue Regeneration Technologies, LLC Pipeline Products by Equipment Type
Tissue Regeneration Technologies, LLC Pipeline Products by Indication
Tissue Regeneration Technologies, LLC, Key Facts
Tissue Regeneration Technologies, LLC, Major Products and Services
Tissue Regeneration Technologies, LLC Number of Pipeline Products by Development Stage
Tissue Regeneration Technologies, LLC Pipeline Products Summary by Development Stage
Cardiogold - Product Status
Cardiogold - Product Description
DermaGold - Product Status
DermaGold - Product Description
OrthoGold 280 - Product Status
OrthoGold 280 - Product Description
Tissue Regeneration Technologies, LLC, Key Employees
Tissue Regeneration Technologies, LLC, Subsidiaries

LIST OF FIGURES

Tissue Regeneration Technologies, LLC Pipeline Products by Equipment Type
Tissue Regeneration Technologies, LLC Pipeline Products by Development Stage
Skip to top


Innovia LLC - Product Pipeline Analysis, 2016 Update US$ 750.00 Feb, 2016 · 41 pages

Ask Your Question

Tissue Regeneration Technologies, LLC - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: